Replies to post #130037 on Biotech Values

[DewDiligence]

Europe’s EMA makes no changes on Pradaxa following evaluation of on-drug deaths:

http://www.reuters.com/article/2011/11/18/boehringer-pradaxa-idUSL5E7MI1VK20111118